January 2006
Partnering with The Vaccine Fund
Progress Report
to the
Global Alliance for Vaccines
and Immunization (GAVI)
and
The Vaccine Fund
by the Government of
COUNTRY:
Islamic Republic of Afghanistan
Date of submission: March, 2006……………
Reporting period: 2005 (
Information provided in this report
MUST refer to
2005 activities )
( Tick only one ) :
Inception report 
First annual progress report 
Second annual progress report 
Third annual progress report
Y
Fourth annual progress report 
Fifth annual progress report 
Text boxes supplied
in this report are meant only to be used as guides. Please feel
free to add text beyond the space provided.
*Unless otherwise
specified, documents may be shared with GAVI partners and collaborators
Progress Report Form: Table
of Contents
Report on progress made
during 2004
Immunization Services
Support (ISS)
1.1.1Management of ISS
Funds
Use of Immunization
Services Support
1.1.3Immunization Data
Quality Audit
GAVI/Vaccine Fund
New and Under-used Vaccines
1.2.1Receipt of new and
under-used vaccines
1.2.2Major activities
Use if GAVI/The
Vaccine Fund financial support (US$100,000) for introduction of the
new vaccine
1.3Injection Safety
Receipt of injection
safety support
Progress of transition
plan for safe injections and safe management of sharps waste
Statement on use
of GAVI/The Vaccine Fund injection safety support (if received in the
form of a cash contribution)
2. Financial Sustainability
3. Request for new and under-used
vaccine for 2006
Up-dated immunization
targets
Confirmed/revised
request for new vaccine (to be shared with UNICEF Supply Division) for
year…
Confirmed/revised
request for injection safety support for the year…
Please report on progress
since submission of the last Progress Report based on the indicators
selected
by your country in the proposal for GAVI/VF support
5. Checklist
6. Comments
7. Signatures
1.
Report on progress made during 2004
To be filled in by the country
for each type of support received from GAVI/The Vaccine Fund.
Immunization Services
Support (ISS)
1.1.1Management of
ISS Funds
Please describe the
mechanism for management of ISS funds, including the role of the Inter-Agency
Co-ordinating Committee (ICC).
Please report on any
problems that have been encountered involving the use of those funds,
such as delay in availability for programme use.
Mechanism
GAVI fund is
managing according to a mechanism that developed by National EPI office
based on standard management tool for management of external grants
and endorsed by ICC members in 2004. Different procedures (The ones
that not existed in MoPH official documents) also developed to facilitate
the management of the fund.
Based on ICC
decision GAVI Fund Management Team established in MoPH and is functional.
Process of fund
release is going through MoPH External Grant Management Unit according
to the action plan, request of national EPI office and approval of His
Excellency Minister of Public Health.
Financial Officer
for GAVI fund management has been assigned in national EPI office and
coordinates the related activities with concerns including Grand and
contract Management Unite (GCMU) of MoPH and treasure department of
Ministry of Finance (MoF).
All action plans
related to GAVI support or any change in the already endorsed action
plans are presented to ICC for the endorsement.
ICC member kept
inform on GAVI expenditures.
GAVI/Vaccine
Fund support is under control of MoPH and considered as part of core
budget of the government. A separate banking account has been opened
for GAVI to facilitate the monitoring and ensure
the support is not used for other purposes rather than EPI.
Problems
Changing the
account number of GAVI in Da Afghanistan Bank (as result of changes
in the management structure of MoF) and miss communication regarding
the new account resulted in delay in
cash transfer to the new account as the GAVI disbursed the cash (March
2005) to the old account number and it took time for the national EPI
office-MoPH to get information on cash disbursement (August 2005) and
transfer the cash to the new account (October 2005). This delay is one
of the reason for low utilization of 2005 ISS fund.
Poor banking
system in the country still existed that together with poor financial
management capacity provincial EPI management teams (PEMT) pushing the
national EPI office for centralized management. Although the planning
process for GAVI fund support is starting from periphery (province and
district). It is plan to delegate some of the financial management responsibilities
to PEMTs in year 2006.
Payment of EPI
staff salaries are responsibility of BPHS (Basic Package of Health Services)
Implementers NGOs but unfortunately some of the NGOs did not included
enough amount for the salary of vaccinators as per MoPH- National
Salary Policy in their proposals. There for the GAVI fund
use for payment of additional incentive to cover the gap and keep
running the EPI canters To avoid it in future GCMU was assigned to ensure
enough budgeting for EPI in future contracts with NGOs. As a temporary
measures all NGOs which has problem of budgeting for EPI are requested
to officially approach MoPH for additional funding to cover the funding
gap..
NGOs receiving
fund per capita for service deliver at the district level. One of the
chalanges that we face was to avoid duplication. In response to it National
Team define role and responsibility of each partners including functional
responsibilities. Some of the BPHS implementers NGOs not planning enough
for EPI. As per MoPH decision Reflection of EPI in both technical and
financial proposals of NGOs is mandatory.
1.1.2Use of Immunization
Services Support
In 2004, the following
major areas of activities have been funded with the GAVI/Vaccine Fund
Immunization Services Support contribution.
Funds received during 2005
____1039000_____
Remaining funds (carry over)
from 2004 _186043_____.
Table 1: Use of funds during
2005
Area of Immunization Services
Support
Total
amount in US $
AMOUNT OF FUNDS
PUBLIC SECTOR
PRIVATE SECTOR & Other
Central
Region/State/Province
District
Vaccines
Injection
supplies
Personnel
175688
38730
6847
130111
Transportation
17460
448
17012
0
Maintenance
and overheads
7318
3920
3398
0
Training
26683
0
6105
20578
IEC
/ social mobilization
15567
9845
5722
0
Outreach
98258
0
0
98258
Supervision
4451
1742
2709
0
Monitoring
and evaluation
11695
0
11695
0
Epidemiological
surveillance
0
0
0
0
Vehicles
Cold
chain equipment
50346
0
0
50346
Other;
(Scanner, Media projector & USB)
2045
2045
0
0
Total:
409511
56730
53488
299293
Remaining
funds for next year:
815532
*If no information
is available because of block grants, please indicate under
‘other’.
Please attach
the minutes of the ICC meeting(s) when the allocation of funds was discussed.
Please report on major
activities conducted to strengthen immunization, as well as,
problems encountered in relation to your multi-year plan.
Major activities:
Conduction of
Regional EPI Review workshop in all regions
Conduction of
National EPI Consensus workshop with active participation of line ministries
and donor and NGO communities.
Conesus on strengthening
of integrated approach with focus on provision of integrated child survival
intervention both in health facilities (one point services delivery)
and at the community level (sustainable out reach and joint intervention).
Pilot implementation of the approach in MoPH strengthening Management
(SM) project.
Submission of
proposal for introduction of DPT-Hepatitis B vaccine to GAVI
Development and
major revision of EPI FSP (accepted)
Establishment
of AEFI surveillance system.
Progress toward
Measles case based surveillance; development of Measles cased Based
Surveillance guideline, Establishment of first Measles Lab in Kabul.
Conduction of
District micro-planning in 301 districts (91.4%).
Strengthening
of Supportive supervision Introduction of pulse immunization and conduction
of the supervision in (171) districts by using a standard tool for supportive
supervision.
Conduction of
pulse immunization in (52) districts.
Improve EPI data
management and provision of feedback to the provinces.
Expansion of
EPI centres from 871 in year 2004 to more than 1050 centres in year
2005.
Strengthening
cold chain system: Construction of provincial vaccine storage facilities
by the support of UNICEF.
Developing Standard
operation Procedures for vaccine management and conduction of vaccine
management training courses for (66) staff.
Refresher Training
Courses for (497 ) vaccinators on EPI and safety of immunization injections
Conduction of
training courses on Measles case based surveillance and surveillance
of AEFI for (393) focal points, PEMT managers and supervisors.
Conduction of
advocacy meetings with donors, involvement of donors in FSP exercise.
Production, distribution
of EPI posters and calendar with EPI messages.
Problems
Restructuring
and reforms of Health system: Hand over of EPI to Basic Package of Health
Services implementers. Low experience of some BPHS implementers’ agencies
regarding management of EPI programs. Uncertainty of role and responsibilities
of different stick holder in the context of BPHS at the provincial level.Coordination
at the provincial to be strengthens.
Reforms of current
EPI structure at the provincial and district level in the context of
new reforms are needed
More focus on
expansion and logistics of EPI rather than system development (High
drop out rate of 14% for DPT and 28% for DPT-Measles).
Only 44 % of
districts with more than 80%DPT-3 coverage
Low measles coverage
and potential risk of out breaks
Immunization
Data Quality Audit (DQA) (If
it has been implemented in your country)
Has a plan of action
to improve the reporting system based on the recommendations from the
DQA been prepared?
If yes, please attach
the plan.
√
YES
NO
If
yes, please report on the degree of its implementation.
Provision of
standard reporting formats
Provision of
29 computers, printers and accessories. All provinces equipped at least
with one set of computer.
Assignment of
Monitoring officer and EPI surveillance officer for national
EPI office
Revision, printing
and distribution of reporting documents (Registration books, tally sheets,
Immunization cards and monthly report forms)
Monitoring of
timeliness and completeness of the reports.
Analysis of the
data at the national level and regular feed back.
Improvement in
the use of EPI monitoring chart.
Introduction
of indicators on quality of registering and reporting in supportive
supervision checklists
Use of Coverage
data for planning during review workshops.
Inclusion of
EPI reporting in the curriculum of EPI training courses for all categories
of EPI staff.
Inclusion of
EPI data quality assessment indicator in EPI supervisory checklist and
conduction/planning for supportive supervision.
Please attach
the minutes of the ICC meeting where the plan of action for the DQA
was discussed and endorsed by the ICC.
Please report on studies conducted regarding EPI issues during 2005
(for example, coverage surveys).
NA
GAVI/Vaccine Fund New
& Under-used Vaccines Support
1.2.1Receipt of new
and under-used vaccines during 2004
Start of vaccinations with
the new and under-used vaccine:
MONTH………………..
YEAR……………….
Please report on receipt
of vaccines provided by GAVI/VF, including problems encountered.
NA
1.2.2Major activities
Please outline major
activities that have been or will be undertaken, in relation to, introduction,
phasing-in, service strengthening, etc. and report on problems encountered.
MoPH- Afghanistan
submitted a proposal to GAVI for support for introduction of DPT-Hep
B vaccine in immunization schedule. All conditions for approval of the
proposal such as provision of realistic target and indicators and Major
revision of FSP were met.
Brusher on DPT-HepB
vaccine in for EPI and health staff in local languages has been developed.
The topic also
discussed in vaccine management training courses that were held for
(66) staff.
General directorate
of Preventive Medicine and PHC was assigned as focal point for the introduction
of the vaccine.
ICC updated regularly
on progress of introduction of the vaccine and EPI task force fully
involved in the process.
It is supposed
to introduce the vaccine in mid 2006 and January 2007.
1.2.3Use of GAVI/The
Vaccine Fund financial support (US$100,000) for the introduction of
the new vaccine
Please report on the
proportion of 100,000 US$ used, activities undertaken, and problems
encountered such as delay in availability of funds for programme use.
NA
Injection
Safety
1.3.1Receipt of injection
safety support
Please report on receipt
of injection safety support provided by GAVI/VF, including problems
encountered
National EPI
office received the second trench of GAVI support for safety of immunization
injection in October year 2005 (650000 US$).
GAVI disbursed
the cash in March of 2005 but the cash was transferred to the old account
of GAVI in Da Afghanistan Bank. Late information on cash disbursement
and lengthy process for transfer of the cash to the new account resulted
in delay in utilization of the fund. Total amount of 11675US$ were used
from this account for safety of immunization injection mainly for IEC,
supervision and training of vaccinators on safety of immunization injection,
Safe waste disposal (497 person) and for the establishment of
surveillance of AEFI. Another reason for low expenditure rate is the
fact that NIP used WHO fund for the training of AFP focal points (393
people) on surveillance of AEFI, production of guidelines and reporting/investigation
format. Low capacity for implementation of the planned activities and
Presence of competing activities such as SIAs is other reasons for low
implementation rate.
Progress of transition
plan for safe injections and safe management of sharps waste.
Please
report problems encountered during the implementation of the transitional
plan for safe injection and sharp waste
Major
Activities:
All EPI centers/teams
provided with required number of AD syringes and safety boxes (UNICEF
support). 100 % of EPI teams are using AD syringes for vaccine injections.
497 vaccinators
were trained on Injection safety, safe waste disposal and detecting
and reporting of AEFI.
Injection safety
and safe immunization wastes disposal are part of supportive supervision
check list. (171) districts were supervised. The analysis of the checklist
shows out of (232) supervisory visits (83 %) of EPI centers were following
safe injection practices as per WHO standards and injection safety National
policy. (This figure is not result of independent assessment)
Surveillance
of AEFI has been established.
312 focal point,
81 provincial EPI management team managers and supervisors have been
trained on AEFI immunization surveillance and safety of injections.
AEFI surveillance
guideline translated in local languages and printed/distributed.
Orientation and
advocacy meetings have been conducted for MoPH policy makers and other
concern.
Safety of injection
included in the agenda of all national and regional EPI workshops
Calendar with
clear safety of immunization injection and safe waste disposal messages
(14 messages and pictures) in local languages developed and printed
(10000 copies) and distributed to all vaccinators and health facilities.
As the GAVI support for
Injection safety ended at the end of 2006 the following measures
are planned for transition of GAVI fund for Injection Safety.
Revision of
National Policy on INS With focus on Bundle supply.
Develop related
legal document on safe injection practices.
Strengthening
surveillance of AEFI
Creating awareness
among communities and service providers.
Periodic assessment
(Provincial level assessment)of Injection safety
Provision of
AD syringes and injection supplies by the support of UNICEF (reflected
in FSP as UNICEF commitment)
Please report on the
progress based on the indicators chosen by your country in the proposal
for GAVI/VF support.
Indicators
Targets
Achievements
Constraints
Updated targets
Provision
of syringes to EPI centres
100%
100%
%
of vaccinators will follow safe immunization injection practices as
per WHO standards
> 95%
83%
- Irregular supervision
with focus on safety of injection some districts.
-Need for further training
of vaccinators considering the rapid expansion of the EPI canters
-No institutionalization
of injection safety and safe waste disposal in health science institutes/medical
university
1.3.3Statement on use
of GAVI/Vaccine Fund injection safety support (if received in the form
of a cash contribution)
The following major
areas of activities have been funded (specify the amount) with the GAVI/The
Vaccine Fund injection safety support in the past year:
Policy, Management
and workshops; 18030
Training on Safe
immunization practices 26845
Management of
used injection collection and safe waste disposal 244436
Surveillance
of AEFI: 21400
Information,
Education and Communication: 76514
Supervision,
monitoring and assessments: 123580
2.
Financial sustainability
Inception
Report:Outline timetable and process for the development of a financial
sustainability plan . Describe assistance that may be needed for developing
a financial sustainability plan.
First Annual
Progress Report: Submit completed financial sustainability plan by given
deadline. Describe major strategies for improving financial sustainability.
Brief
Background:
FSP has been
developed and submitted in March 2005 and reviewed by IRC.
As per IRC recommendation
the FSP revised (Major revision) and resubmitted in October 2005.
The IRC reviewed
the revised FSP in November and accepted.
In all the stages
of developing and revision of FSP the members of ICC including MoF and
donor agencies fully involved and updated.
The exercise
helps the MoPH to identify gaps and need for government financial contribution.
Government financial contribution from it’s own resources will
be start in year 2008 to cover partially the cost of hep B vaccine and
there after the government will develop Vaccine Self Reliance Initiative
to sustain government financial contribution as part of a common basket
as mentioned in Afghanistan FSP.
Summary of strategies:
Mobilizing additional
resources:
Mobilizing domestic resources
as key strategy toward financial sustainability with focus to:
Improve budgetary
resources allocated to immunization.
Develop long-term
immunization plan for vaccine management and cold chain
Propose vaccine
self-reliance initiative with target for government allocation in a
common basket for purchasing traditional vaccines and renovation of
cold chain for long term prospective.
Increase
donor funding for immunization
To ensure the
already committed funds are used efficiently through proper funding
of all important components
To advocate for
increased funding with all current and potentially new donors,
To channel and
mange the BPHS fund through MoPH mechanism as part of government core
budget.
Mobilize
resources from private sectors with focus on institutionalizing of the
possible role of the private sector in prevention and immunization.
Ensure
reliability of resources:
Ensure financial
requirements for immunization are properly reflected in NDB.
Ensure Government
contributions for new vaccines purchase are protected.
Ensure Confidence
is maintained within donor communities in the program.
Ensure immunization
forecast incorporated and protected into the planning and budgeting
cycles of the Government.
Ensure the new
vaccine expenditure covered by the Government.
Advocacy for
possible extension of GAVI support for a period beyond 2008.
Improve accountability.
Increase
the efficiency of the resources
Enforce
of integrated approach and maximize utilization of the immunization
sessions (fixed and out reach).
Reduce
vaccine wastage
Use
of private providers to provide immunization services
Subsequent
Progress Reports:According to current GAVI rules, support for new and
under-used vaccines is covering the total quantity required to meet
country targets (assumed to be equal to DTP3 targets) over a five year
period (100% x 5 years = 500%). If the requested amount of new
vaccines does not target the full country in a given year (for example,
a phasing in of 25%), the country is allowed to request the remaining
(in that same example: 75%) in a later year. In an attempt to
help countries find sources of funding in order to attain financial
sustainability by slowly phasing out GAVI/VF support, they are encouraged
to begin contributing a portion of the vaccine quantity required.
Therefore, GAVI/VF support can be spread out over a maximum of ten years
after the initial approval, but will not exceed the 500% limit (see
figure 4 in the GAVI Handbook for further clarification). In table
2.1, specify the annual proportion of five year GAVI/VF support for
new vaccines that is planned to be spread-out over a maximum of ten
years and co-funded with other sources. Please add the three rows
(Proportion funded by GAVI/VF (%), Proportion funded by the Government
and other sources (%), Total funding for
…………. (new vaccine)) for each new vaccine.
Table
2.1: Sources (planned) of financing of new vaccine
………(NA)…………… (specify)
Proportion of vaccines supported
by *
Annual
proportion of vaccines
20..**
20..
20..
20..
20..
20..
20..
20..
20..
20..
A: Proportion funded by GAVI/VF
(%)***
B: Proportion funded by the Government
and other sources (%)
C: Total funding for …………. (new vaccine)
* Percentage
of DTP3 coverage (or measles coverage in case of Yellow Fever) that
is target for vaccination with a new and under-used
vaccine.
** The first year should
be the year of GAVI/VF new vaccine introduction
*** Row A should total 500%
at the end of GAVI/VF support
In table 2.2 below, describe
progress made against major financial sustainability strategies and
corresponding indicators.
Table 2.2:Progress against
major financial sustainability strategies and corresponding indicators
Financial Sustainability Strategy
Specific
Actions Taken Towards Achieving Strategy
Progress
Achieved
Problems
Encountered
Baseline
Value of Progress Indicator
Current
Value of Progress Indicator
Proposed
Changes To Financial Sustainability Strategy
Mobilizing
government resources
EPI requirement reflected
in NDB
EPI staff involved in budgeting
exercise
NDB to be finalized
% of GoA financial contribution
in cost of new vaccine = 0%
0%
Target for government financial
commitment proposed
GoA contribution in routine
EPI financing proposed for government 5 years budgeting cycle
Other competing health priorities
% of GoA contribution in routine
EPI financing =10%
17%
All EPI partners to be involved
in MYPoA exercise
Processes of developing MYPoA
completed 80%
Complete post expenditures
to be collected
Plan developed = 0
0
Mobilize
donor funding for immunization
Steps has been taken for EPI
financial monitoring system development
NGOs expenditure information
sheet distributed and preliminary analysis done
financial information system
is still weak
% of NGO contribution in routine
EPI cost = 20%
24%
Advocacy with donors in the
course of consensus workshop and meeting to chanalize fund through MoPH
USAID has handover the management
of it’s support for BPHS partially to MoPH
First batches of the contract
with BPHS implementers is ending in 2006
0
1
Up date donors and partners
on financial issues related to EPI has been doon
Financial report on EPI expenditures
(GAVI) discussed in ICC and CGHN meetings
Reports is only cover financial
information of GAVI fund
Number of reports generated
= 0
2
Mobilize
resources from private sector
No activity has been conducted
so fore
0%
0%
Ensure
reliability of resources
NIP budget incorporated in
MoPH annual budget
EPI requirements reflected
in NDB for 2006
% of GoA funded program secured
in NDB =
Enforce
integration and maximize efficiency of immunization
Integrated services deliver
both at health facility and out reach sites initiated
Pilot integrated project initiated
in 82 health facilities in 18 districts in SM provinces.
Low capacity of implementers,
Need for EPI policy revision
% of districts followed one
point services delivery = 0%
5.4%
Tools and guidelines for district
micro-planning has been developed
District micro planning conducted
in (91%) districts with focus on rescheduling of out reach sessions
% of districts with micro-plan
= 46%
91%
Measures including provision
of feedback and strengthening supervision has been implemented for reduction
of Drop out rate
DPT Drop out rate reduced
to 14% in year 2005
Presences of low performance
district
DPT dropout rate = 17%
14%
Reduce
vaccine wastage
Vaccine wastage monitoring
system
Not established
Measure such as training courses
and developing SOPs implemented.
Vaccine management training
courses conducted for 66 staff
Still high for measles &
BCG
DPT vaccine wastage rate =
27%
20%
3.
Request for new and under-used vaccines for year 2006
Section
3 is related to the request for new and under used vaccines and injection
safety for 2006.
Up-dated
immunization targets
Confirm/update basic data approved with country application: figures
are expected to be consistent with those reported in the WHO/UNICEF
Joint
Reporting Forms. Any changes and/or discrepancies MUST
be justified in the space provided (page 12). Targets for future years
MUST be provided.
Table
3 : Update of immunization achievements and annual targets
Number of
Achievements
and targets
2005
2006
2007
2008
2009
2010
2011
2012
2013
DENOMINATORS
Births
1215335
1244503
1274371
1304955
1336274
1368345
1401185
1434813
1469249
Infants’
deaths
170147
168008
163119
157900
152335
146416
140119
136307
132232
Surviving
infants
1045188
1076495
1111252
1147055
1183939
1221932
1261067
1298506
1337016
Infants
vaccinated in 2005 (JRF) / to be vaccinated in 2006 and beyond with
1st dose of DTP (DTP1)*
922821
1001391
Infants
vaccinated 2005 (JRF) / to be vaccinated in 2006 and beyond with 3rd
dose of DTP (DTP3)*
798064
861196
NEW
VACCINES **
Infants vaccinated 2005 (JRF)
/ to be vaccinated in 2006 and beyond with 1st
dose of DTP (DTP1)* Hepatitis-B.... (new vaccine)
0
0
1055689
1101173
1160260
1197493
1248456
1285521
1323646
Infants
vaccinated 2005 (JRF) / to be vaccinated in 2006 and beyond with 3rd
dose of Hepatitis-B ( new vaccine)
922339
974997
1041866
1099739
1160181
1220595
1270165
Wastage
rate in 2005 and plan for 2006 beyond*** Hepatitis-B.. ( new vaccine)
20%
20%
20%
20%
15%
15%
15%
15%
15%
INJECTION
SAFETY****
Pregnant women vaccinated in 2005
(JRF) / to be vaccinated in 2006 and beyond with TT2
587344
995602
1019497
1043964
1069019
1163093
1191007
1233939
1278246
Infants
vaccinated in 2005 (JRF) / to be vaccinated in 2006 and beyond with
BCG *
889629
995602
1057728
1148360
1202647
1272561
1331126
1337420
1439864
Infants
vaccinated in 2005 (JRF) / to be vaccinated in 2006 and beyond with
Measles *
667152
807371
866776
952056
1018187
1063081
1109739
1155670
1243425
* Indicate actual number
of children vaccinated in 2005 and updated targets (with either DTP
alone or combined)
** Use 3 rows (as indicated
under the heading NEW VACCINES) for every new vaccine introduced
*** Indicate actual wastage
rate obtained in past years
**** Insert any row as
necessary
Please provide justification
on changes to baseline, targets, wastage rate, vaccine presentation,
etc. from the previously approved plan, and on reported figures which
differ from those reported in the WHO/UNICEF Joint Reporting Form in
the space provided below.
The number of
survival infants calculated based on the new agreed bench marks for
Infant Mortality Rate that is 140 for 2005 and it is supposed to reach
to 107 till end of 2010 and to 77 till 2015.
NIP revised the
target for DPT/DPT-HepB and other antigen based on 2005 achievement
in order to make more realistic and achievable
The target for
drop out rate also revised accordingly as the program reduced the DPT
drop out to 14% in year 2005.
3.2Availability
of revised request for new vaccine (to
be shared with UNICEF Supply Division) for 2007
In
case you are changing the presentation of the vaccine, or increasing
your request; please indicate below if UNICEF Supply Division has assured
the availability of the new quantity/presentation of supply.
UNICEF
country office is providing vaccine and injection supplies both for
routine and supplementary immunization according to the stated national
coverage target.
Table 4:
Estimated number of doses of DPT-Hepatitis
vaccine(specify for one presentation only):
Please repeat this table for any other vaccine presentation requested
from
GAVI/The
Vaccine Fund (Please note that the anticipated vaccine in stock
is Zero as mentioned in the relevant row)
*Please report the same
figure as in table 3.
Table 5: Wastage rates and
factors
Vaccine wastage rate
5%
10%
15%
20%
25%
30%
35%
40%
45%
50%
55%
60%
Equivalent
wastage factor
1.05
1.11
1.18
1.25
1.33
1.43
1.54
1.67
1.82
2.00
2.22
2.50
3.3Confirmed/revised request
for injection safety support for the years 2007 -2008
Table 6: Estimated supplies
for safety of vaccination for the next two years with
…… (Use one table for each vaccine BCG, DTP, measles and
TT, and number them from 4 to 8)
Table 6-4
Table-6-5
Table 6-7
If quantity of current
request differs from the GAVI letter of approval, please present the
justification for that difference.
The
quantity is adjusted according to the new coverage target (Please see
part 3-1 and justification for revision of baseline and targets).
4.
Please report on progress since submission of the last Progress Report
based on the indicators selected by your country in the proposal for
GAVI/VF support
Indicators
Targets
Achievements
Constraints
Updated targets
DPT-3
Coverage Rate 2004
65%
66%
DPT-3
Coverage Rate, 2005
80%
76%
DPT Dropout
Rate 2004
16%
17%
DPT-drop-our
rate, 2005
16%
14%
Checklist
Checklist of completed form:
Form
Requirement:
Completed
Comments
Date of submission
Y
Reporting
Period (consistent with previous calendar year)
Y
Table 1 filled-in
Y
DQA reported
on
Y
Reported
on use of 100,000 US$
NA
Injection
Safety Reported on
Y
FSP Reported
on (progress against country FSP indicators)
Y
Table 2 filled-in
NA
New Vaccine
Request completed
Y
Revised request
for injection safety completed (where applicable)
Y
ICC minutes
attached to the report
Y
Government
signatures
Y
ICC endorsed
Y
6.
Comments
ICC/RWG comments:
On
14th of May the ICC members reviewed the report and the recommendation
are incorporated in the report
~ End ~
DRAFT
JANUARY 2001